BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fizpatrick MM, Walters MD, Trompeter RS, Dillon MJ, Barratt TM. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. The Journal of Pediatrics 1993;122:532-7. [DOI: 10.1016/s0022-3476(05)83531-0] [Cited by in Crossref: 71] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Rock G, Kolajova M, Faught C, Zimmerman D. Identification of plasma antifibrin/fibrinogen antibodies in a patient with hemolytic uremic syndrome. Blood Coagul Fibrinolysis 2006;17:539-44. [PMID: 16988548 DOI: 10.1097/01.mbc.0000245299.72268.aa] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB; European Paediatric Study Group for HUS. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 2009;24:687-96. [PMID: 18800230 DOI: 10.1007/s00467-008-0964-1] [Cited by in Crossref: 225] [Cited by in F6Publishing: 173] [Article Influence: 16.1] [Reference Citation Analysis]
3 Bonetti V, Mangia CM, Zuza JM, Barcelos MO, Fonseca MM, Nery SP, Carvalhaes JT, Andrade MC. Hemolytic-Uremic Syndrome in Uberlândia, MG, Brazil. ISRN Pediatr 2011;2011:651749. [PMID: 22389782 DOI: 10.5402/2011/651749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Buder K, Latal B, Nef S, Neuhaus TJ, Laube GF, Spartà G. Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome. Pediatr Nephrol 2015;30:503-13. [PMID: 25234636 DOI: 10.1007/s00467-014-2950-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
5 Siegler RL, Pavia AT, Sherbotie JR. Recurrent hemolytic uremic syndrome. Clin Pediatr (Phila) 2002;41:705-9. [PMID: 12462321 DOI: 10.1177/000992280204100910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Elliott EJ, Robins-Browne RM, O'Loughlin EV, Bennett-Wood V, Bourke J, Henning P, Hogg GG, Knight J, Powell H, Redmond D; Contributors to the Australian Paediatric Surveillance Unit. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 2001;85:125-31. [PMID: 11466187 DOI: 10.1136/adc.85.2.125] [Cited by in Crossref: 142] [Cited by in F6Publishing: 117] [Article Influence: 6.8] [Reference Citation Analysis]
7 Loirat C, Niaudet P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol. 2003;18:1095-1101. [PMID: 13680331 DOI: 10.1007/s00467-003-1289-8] [Cited by in Crossref: 109] [Cited by in F6Publishing: 71] [Article Influence: 5.7] [Reference Citation Analysis]
8 Filler G, Radhakrishnan S, Strain L, Hill A, Knoll G, Goodship TH. Challenges in the management of infantile factor H associated hemolytic uremic syndrome. Pediatr Nephrol 2004;19:908-11. [PMID: 15206027 DOI: 10.1007/s00467-004-1526-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
9 Godron A, Pereyre S, Monet C, Llanas B, Harambat J. Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection. Pediatr Nephrol 2013;28:2057-60. [PMID: 23800801 DOI: 10.1007/s00467-013-2541-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Cheong HI, Lee BS, Kang HG, Hahn H, Suh KS, Ha IS, Choi Y. Attempted treatment of factor H deficiency by liver transplantation. Pediatr Nephrol 2004;19:454-8. [PMID: 14986080 DOI: 10.1007/s00467-003-1371-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
11 Medhioub Kaaniche F, Chaari A, Bacouch N, Bahloul M, Bouaziz M. Syndrome hémolytique et urémique de l’adulte jeune par trouble du métabolisme de la cobalamine : à propos d’un cas. La Presse Médicale 2016;45:148-50. [DOI: 10.1016/j.lpm.2015.10.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Provaznikova D, Rittich S, Malina M, Seeman T, Marinov I, Riedl M, Hrachovinova I. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP. Pediatr Nephrol. 2012;27:73-81. [PMID: 21706448 DOI: 10.1007/s00467-011-1943-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
13 Ruebner RL, Kaplan BS, Copelovitch L. A time for reappraisal of "atypical" hemolytic uremic syndrome: should all patients be treated the same? Eur J Pediatr 2012;171:1519-25. [PMID: 22673930 DOI: 10.1007/s00431-012-1763-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
14 Renaud C, Niaudet P, Gagnadoux MF, Broyer M, Habib R. Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age. Pediatr Nephrol 1995;9:24-9. [PMID: 7742216 DOI: 10.1007/BF00858960] [Cited by in Crossref: 29] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
15 Kavukçu S, Irken G, Olgun N, Güçlü A. Atypical hemolytic uremic syndrome. Acta Paediatr Jpn 1995;37:638-41. [PMID: 8533595 DOI: 10.1111/j.1442-200x.1995.tb03393.x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
16 Neuhaus TJ, Calonder S, Leumann EP. Heterogeneity of atypical haemolytic uraemic syndromes. Arch Dis Childhood. 1997;76:518-521. [PMID: 9245850 DOI: 10.1136/adc.76.6.518] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
17 Sharma AP, Greenberg CR, Prasad AN, Prasad C. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. Pediatr Nephrol 2007;22:2097-103. [PMID: 17874135 DOI: 10.1007/s00467-007-0604-1] [Cited by in Crossref: 76] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
18 Kaplan BS, Ruebner RL, Copelovitch L. Eculizumab treatment of atypical hemolytic uremic syndrome. Expert Opinion on Orphan Drugs 2012. [DOI: 10.1080/21678707.2013.750579] [Reference Citation Analysis]